Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenke Scheen

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Crystallographic fragment screening and deep mutational scanning of Zika virus NS2B-NS3 protease enable development of resistance-resilient inhibitorsXiaomin Ni, R Blake Richardson, Andre Schutzer Godoy, et al.
Nature Communications|October 8, 2025
Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitorsXiaomin Ni, R Blake Richardson, Andre Schutzer Godoy, et al.
Journal of Chemical Information and Modeling|May 21, 2026
Large-Scale Collaborative Assessment of Binding Free Energy Calculations for Drug Discovery Using OpenFEHannah M Baumann, Joshua T Horton, Michael M Henry, et al.
Journal of Chemical Information and Modeling|February 26, 2026
A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery DataHugo MacDermott-Opeskin, Jenke Scheen, Cas Wognum, et al.
Science (New York, N.Y.)|November 9, 2023
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitorsMelissa L Boby, Daren Fearon, Matteo Ferla, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Crystallographic fragment screening and deep mutational scanning of Zika virus NS2B-NS3 protease enable development of resistance-resilient inhibitorsXiaomin Ni, R Blake Richardson, Andre Schutzer Godoy, et al.
Nature Communications|October 8, 2025
Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitorsXiaomin Ni, R Blake Richardson, Andre Schutzer Godoy, et al.
Journal of Chemical Information and Modeling|May 21, 2026
Large-Scale Collaborative Assessment of Binding Free Energy Calculations for Drug Discovery Using OpenFEHannah M Baumann, Joshua T Horton, Michael M Henry, et al.
Journal of Chemical Information and Modeling|February 26, 2026
A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery DataHugo MacDermott-Opeskin, Jenke Scheen, Cas Wognum, et al.
Science (New York, N.Y.)|November 9, 2023
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitorsMelissa L Boby, Daren Fearon, Matteo Ferla, et al.
Pageof 2